Skip to main content
Log in

Delirious Mania and Malignant Catatonia: A Report of 3 Cases and Review

  • Original Paper
  • Published:
Psychiatric Quarterly Aims and scope Submit manuscript

Abstract

Delirious mania is often difficult to distinguish from excited catatonia. While some authors consider delirious mania a subtype of catatonia, the distinction between the two entities is important as treatment differs and effects outcome. It appears that as catatonia is described as having non-malignant and malignant states, the same division of severity may also apply to delirious mania. Non-malignant delirious mania meets the criteria for mania and delirium without an underlying medical disorder. The patients are amnestic, may lose control of bowel and bladder, but still respond to atypical antipsychotics and mood stabilizers. However, with increasing progression of the disease course and perhaps with an increasing load of catatonic features, delirious mania may convert to a malignant catatonic state (malignant delirious mania) which is worsened by antipsychotics and requires a trial of benzodiazepines and/or ECT. Three case reports are presented to illustrate the diagnostic conundrum of delirious mania and several different presentations of malignant catatonia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Calmeil LF: Dictionnaire de medicine: ou, repertoire general des sciences medicales considerees sous le rapport theorique et pratique. 2edn. Paris, Bechet, 1832

    Google Scholar 

  2. Fink M: Delirious mania. Bipolar Disorders 1:54–60, 1999. doi:10.1034/j.1399-5618.1999.10112.x

    Article  PubMed  CAS  Google Scholar 

  3. Fink M, Taylor MA: The many varieties of catatonia. European Archives of Psychiatry and Clinical Neuroscience 251(1):I8–13, 2001. doi:10.1007/PL00014200

    PubMed  Google Scholar 

  4. Friedman RS, Mufson MJ, Eisenberg TD, Patel MR: Medically and psychiatrically ill: The challenge of delirious mania. Harvard Review of Psychiatry 11:91–98, 2003. doi:10.1080/10673220303960

    Article  PubMed  Google Scholar 

  5. Karmacharya R, England ML, Ongur D: Delirious mania: Clinical features and treatment response. Journal of Affective Disorders 109:312–316, 2008. doi:10.1016/j.jad.2007.12.001

    Article  PubMed  Google Scholar 

  6. Bell L: On a form of disease resembling some advanced stages of mania and fever, but so contradistinguished form ordinarily observed or described combination of symptoms as to render it probable that it may be an overlooked and hitherto unrecorded malady. American Journal of Insanity 6:97–127, 1849

    Google Scholar 

  7. Lewis WB: A Text-Book of Mental Diseases: With special reference to the pathological aspects of insanity. London, Griffin, 1889

    Google Scholar 

  8. Dercum FX: A Clinical Manual of Mental Diseases. Philadelphia, London WB Saunders, 1917

    Google Scholar 

  9. Alzheimer A: Das delirum acutum. Monatsschrift fuer Psychiatrie und Neurologie 2:64–65, 1897

    Google Scholar 

  10. Berkley HJ: A Treatise on Mental Disease Based on the Lecture Course at the Johns Hopkins University 1899 and Designed for the Use of Practitioners and Students of Medicine. New York, D Appleton & Company, 1900

    Google Scholar 

  11. Binswanger O, Berger, H: Zur klinik und pathologischen anatomie der postinfectiosen und intoxicationspsychosen. European Archives of Psychiatry and Clinical Neuroscience 34:107–139, 1901

    Google Scholar 

  12. Church A, Peterson F: Nervous and Mental Diseases. Philadelphia London, WB Saunders Company, 1911

    Google Scholar 

  13. Hoch A: Benign Stupors; A Study of a New Manic-Depressive Type. New York, Macmillan Publishing Co, Inc. 1–50:149–173, 1921

  14. Bowers PE: Manual of psychiatry for the medical student and general practitioner. Philadelphia, Saunders, 1924

    Google Scholar 

  15. Stauder KH: Die todliche Katatonie. Archiv für Psychiatrie und Nervenkrankheiten 102:614–634, 1934. doi:10.1007/BF01813829

    Article  Google Scholar 

  16. Kraines SH: Bell’s mania. American Journal of Psychiatry 91:29–40, 1934

    Google Scholar 

  17. Mann SC, Caroff SN, Bleier HR, Welz WKR, Kling MA, Hayashida M: Lethal catatonia. American Journal of Psychiatry 143:1374–1381, 1986

    PubMed  CAS  Google Scholar 

  18. Philbrick KL, Rummans TA. Malignant catatonia. The Journal of Neuropsychiatry and Clinical Neurosciences 6:1–13, 1994

    PubMed  CAS  Google Scholar 

  19. Stromgren LS: ECT in acute delirum and related clinical states. Convulsive Therapy 13:10–17, 1997

    PubMed  CAS  Google Scholar 

  20. Taylor MA, Fink M: Catatonia as a psychiatric classification: Home of its own. American Journal of Psychiatry 160:1233–1241, 2003. doi:10.1176/appi.ajp.160.7.1233

    Article  PubMed  Google Scholar 

  21. Fink M, Taylor M: Catatonia: Subtype or syndrome in DSM? American Journal of Psychiatry. 163:1875–1876, 2006. doi:10.1176/appi.ajp.163.11.1875

    Article  PubMed  Google Scholar 

  22. Kahlbaum K: Die Katatinie oder das Spannungssirresein, Berlin, a. Hirschwald (Translated: Kahlabuam K (1973) Catatonia. Johns Hopkins University Press, Baltimore, 1874

    Google Scholar 

  23. Pommepuy N, Januel D: La catatonie: resurgence d’un concept. Une revue de la litterature internationale. Encephale 27:481–492, 2002

    Google Scholar 

  24. Bush G, Fink M, Petrides G, Dowling F, Francis A: Catatonia. I. Rating scale and standardized examination. Acta Psychiatrica Scandinavica 93:129–136, 1996a. doi:10.1111/j.1600-0447.1996.tb09814.x

    Article  PubMed  CAS  Google Scholar 

  25. Peralta V, Cuesta MJ, Serrano JF, Mata I: The Kahlbaum syndrome: a study of its clinical validity, nosological status, and relationship with schizophrenia and mood disorder. Comprehensive Psychiatry 38:61–67, 1997. doi:10.1016/S0010-440X(97)90055-9

    Article  PubMed  CAS  Google Scholar 

  26. Braunig P, Kruger S, Shagur G, Hoffler J, Borer I: The catatonia rating scale I: development, reliability, and use. Comprehensive Psychiatry 41:147–158, 2000. doi:10.1016/S0010-440X(00)90148-2

    Article  PubMed  CAS  Google Scholar 

  27. Rogers D: Motor Disorder in Psychiatry: Towards a Neurological Psychiatry. Chichester UK, John Wiley & Sons, 1992

    Google Scholar 

  28. Taylor MA: Catatonia: A review of behavioral neurologic syndrome. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 3:48–72, 1990

    Google Scholar 

  29. Fink M. Catatonia: In: Trimble M, Cummings J (Eds), Contemporary Behavioral Neurology. Butterworth/Heinemann, Oxford, pp 289–309, 1997

  30. Fink M, Taylor MA: Catatonia: A Clinician’s Guide to Diagnosis and Treatment. Cambridge, UK, Cambridge University Press, 2003

    Google Scholar 

  31. Van Den Eede F, Van Hecke J, Van Dalfsen A, Van den Bossche B, Cosyns P, Sabbe BG: The use of atypical antipsychotics in the treatment of catatonia. European Psychiatry 20:422–429, 2005. doi:10.1016/j.eurpsy.2005.03.012

    Article  Google Scholar 

  32. Nelson R, Furner S, Jesudason V, et al.: Fecal incontinence in Wisconsin nursing homes. Diseases of the Colon and Rectum 41:1226–1229, 1998. doi:10.1007/BF02258218

    Article  PubMed  CAS  Google Scholar 

  33. Bond TC: Recognition of acute delirious mania. Archives of General Psychiatry 37:553–554, 1980

    PubMed  CAS  Google Scholar 

  34. Gelenberg AJ: The catatonic syndrome. Lancet 1:1339–1341, 1976. doi:10.1016/S0140-6736(76)92669-6

    Article  PubMed  CAS  Google Scholar 

  35. www.stelazine.com/; referenced March 29, 2008

  36. www.merck.com/mmpe/lexicomp/trifluoperazine.html; referenced March 29, 2008

  37. Goldman SA: Lithium and neuroleptics in combination: the spectrum of neurotoxicity [corrected] Psychopharmacology bulletin 32:299–309. Erratum in: Psychopharmacology Bulletin 32:544, 1996

    Google Scholar 

  38. Markham-Abedi C, McNeely C, de Leon J: A case report with ziprasidone-induced catatonic symptoms. The Journal of Neuropsychiatry and Clinical Neurosciences 19:476–477, 2007. doi:10.1176/appi.neuropsych.19.4.476

    PubMed  Google Scholar 

  39. Borovicka MC, Bond LC, Gaughan KM: Ziprasidone- and Lithium-induced Neuroleptic Malignant Syndrome. The Annals of Pharmacotherapy 40:139–142, 2005. doi:10.1345/aph.1G470

    Article  PubMed  Google Scholar 

  40. Filice GA, McDougall BC, Ercan-Fang N, Billington CJ: Neuroleptic malignant syndrome associated with olanzapine. The Annals of Pharmacotherapy 32:1158–1159, 1998. doi:10.1345/aph.18151

    Article  PubMed  CAS  Google Scholar 

  41. Berry N, Pradhan S, Sagar R, Gupta SK: Neuroleptic malignant syndrome in an adolescent receiving olanzapine-lithium combination therapy. Pharmacotherapy 23:255–259, 2003. doi:10.1592/phco.23.2.255.32091

    Article  PubMed  Google Scholar 

  42. Tolsma FJ: The syndrome of acute pernicious psychosis. Psychiatria, Neurologia, Neurochirurgia 70:1–21, 1967

    PubMed  CAS  Google Scholar 

  43. Chrisstoffels J, Thiel JH: Delirium acutum, a potentially fatal condition in the psychiatric hospital. Psychiatria, Neurologia, Neurochirurgia 73:177–187, 1970

    PubMed  CAS  Google Scholar 

  44. Fox FL, Bostwick JM: Propofol sedation of refractory delirious mania. Psychosomatics 38:288–290, 1997

    PubMed  CAS  Google Scholar 

  45. Shulack NR: Sudden “exhaustive” death in excited patients. The Psychiatric Quarterly 18:3–12, 1944. doi:10.1007/BF01569018

    Article  Google Scholar 

  46. Shulack NR: Exhaustion syndrome in excited psychotic patients. American Journal of Psychiatry 102:466–475, 1946

    Google Scholar 

  47. Lingjaerde O: Contributions to the study of schizophrenia and the acute malignant deliria. Journal of the Oslo City Hospitals 14:43–83, 1963

    Google Scholar 

  48. Bush G, Fink M, Petrides G, Dowling F, Francis A: Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatrica Scandinavica 93:137–43, 1996b. doi:10.1111/j.1600-0447.1996.tb09815.x

    Article  PubMed  CAS  Google Scholar 

  49. Arnold OH, Stepan H: Untersuchungen zur Frage der akuten todlichen Katatonie. Wiener Zeitschrift fur Nervenheilkunde und Deren Grenzgebiete 4:235–258, 1552

    Google Scholar 

  50. Sedivec V: Psychoses endangering life. Ceskoslovenská psychiatrie 77:38–41, 1981

    PubMed  CAS  Google Scholar 

  51. Hafner H, Kasper S: Akute lebensbedrohliche Katatonie: Epdemiologische und Klinische Befunde. Nervenzart 53:385–394, 1982

    CAS  Google Scholar 

  52. Beckmann H, Franzek E, Stöber G: Genetic heterogeneity in catatonic schizophrenia: A family study. American Journal of Medical Genetics 67:289–300, 1996. doi:10.1002/(SICI)1096-8628(19960531)67:3<289::AID-AJMG5>3.0.CO;2-I

    Google Scholar 

  53. Stöber G, Franzek E, Lesch KP, Beckmann H: Periodic catatonia: A schizophrenic subtype with major gene effect and anticipation. European Archives of Psychiatry and Clinical Neuroscience 245(3):135–141, 1995. doi:10.1007/BF02193085

    Article  PubMed  Google Scholar 

  54. Stöber G, Saar K, Rüschendorf F, Meyer J, Nürnberg G, Jatzke S, Franzek E, Reis A, Lesch KP, Wienker TF, Beckmann H: Splitting schizophrenia: Periodic catatonia-susceptibility locus on chromosome 15q15. American Journal of Human Genetics 67:1201–1207, 2000

    PubMed  Google Scholar 

  55. Huang TL: Lorazepam and diazepam rapidly relieve catatonic signs in patients with schizophrenia. Psychiatry and Clinical Neurosciences 59(1):52–55, 2005. doi:10.1111/j.1440-1819.2005.01331.x

    Article  PubMed  CAS  Google Scholar 

  56. Martényi F, Metcalfe S, Schausberger B, Dossenbach MR: An efficacy analysis of olanzapine treatment data in schizophrenia patients with catatonic signs and symptoms. The Journal of Clinical Psychiatry 62(2):25–27, 2001

    PubMed  Google Scholar 

  57. Kraepelin E: Manic-Depressive Insanity and Paranoia. Edinburgh, E & S Livingstone, pp 70–74, 1921

    Google Scholar 

  58. Whalley N, Diaz P, Howard J: Neuroleptic malignant syndrome associated with the use of quetiapine. The Canadian Journal of Hospital Pharmacy 52:112, 1999

    Google Scholar 

  59. Powers P, Scott DT, Waziri R: Hyperpyrexia in catatonic states. Diseases of the Nervous System 37:359–361, 1976

    PubMed  CAS  Google Scholar 

  60. O’Toole JK, Dyck G: Report of psychogenic fever in catatonia responding to electroconvulsive therapy. Diseases of the Nervous System 38:852–853, 1977

    PubMed  CAS  Google Scholar 

  61. Pruett JR, Rizvi ST: A16-year-old girl with excited catatonia treated with low-dose oral Lorazepam. Journal of Child and Adolescent Psychopharmacology 15(6):1005–1010, 2005. doi:10.1089/cap.2005.15.1005

    Article  PubMed  Google Scholar 

  62. Manjunatha N, Saddichha S, Khess CR: Idiopathic recurrent catatonia needs maintenance lorazepam: case report and review. The Australian and New Zealand Journal of Psychiatry 41:625–627, 2007. doi:10.1080/00048670701400032

    Article  PubMed  Google Scholar 

  63. Stanley AK, Hunter J: Possible neuroleptic malignant syndrome and quetiapine. The British Journal of Psychiatry 176:497, 2000. doi:10.1192/bjp.176.5.497-a

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mark B. Detweiler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Detweiler, M.B., Mehra, A., Rowell, T. et al. Delirious Mania and Malignant Catatonia: A Report of 3 Cases and Review. Psychiatr Q 80, 23–40 (2009). https://doi.org/10.1007/s11126-009-9091-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11126-009-9091-9

Keywords

Navigation